NLRP1 and diabetic kidney disease: Moreover, Fucoidan (FPS) inhibits NLRP3 inflammasome-mediated podocyte pyroptosis by modulating the AMPK/mTORC3/NLRP1 signaling axis in DKD, thereby alleviating DKD (Wang et al. 2022a, b, c).